Institution statistics

BOEHRINGER INGELHEIM PHARMA GMBH &CO KG -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:> 1000
Total Number of Projects:300-400
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 30
As coordinator: 0
As participant: 30
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 34.601.665 0 2
2020 0 85.107.848 252.788 5
2019 0 45.677.464 252.788 5
2018 0 15.942.861 0 2
2017 0 55.675.195 0 6
2016 0 33.556.083 463.820 4
2013 0 6.485.847 0 1
2012 0 11.174.600 307.640 2
2010 0 9.834.779 0 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA11
PFIZER LIMITED10
JANSSEN PHARMACEUTICA NV9
BAYER7
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN7
ABBVIE INC6
F HOFFMANNLA ROCHE6
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V6
NOVO NORDISK6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
UCB BIOPHARMA6
ELI LILLY AND COMPANY LIMITED5
INSTITUT DE RECHERCHES SERVIER5
KATHOLIEKE UNIVERSITEIT LEUVEN5
LEIDS UNIVERSITAIR MEDISCH CENTRUM5
UNIVERSITAET BERN5
UNIVERSITY OF DUNDEE5
ASTRAZENECA4
ASTRAZENECA AB4
EBERHARD KARLS UNIVERSITAET TUEBINGEN4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
MEDIZINISCHE UNIVERSITAET WIEN4
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT4
ASTELLAS PHARMA EUROPE BV3
BAYER AKTIENGESELLSCHAFT3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER3
JDRF INTERNATIONAL3
LUNDS UNIVERSITET3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
MERCK SHARP & DOHME CORP3
SANOFIAVENTIS3
SANOFIAVENTIS DEUTSCHLAND3
TAKEDA PHARMACEUTICALS INTERNATIONAL3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITAT WIEN3
UNIVERSITEIT LEIDEN3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF HELSINKI3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ALLERGAN LIMITED2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
CERTARA UK LIMITED2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
LINKOPINGS UNIVERSITET2
LIPOTYPE2
MEDTRONIC INTERNATIONAL TRADING SARL2
MOLECULAR NETWORKS GMBH COMPUTERCHEMIE2
ORION OYJ2
OWKIN FRANCE2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE2
STATENS LEGEMIDDELVERK2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING LYGATURE2
STICHTING VUMC2
SYDDANSK UNIVERSITET2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF EXETER2
THE UNIVERSITY OF NOTTINGHAM2
TRANSGENE2
UNIVERSITA CATTOLICA DEL SACRO CUORE2
UNIVERSITAET ZU LUEBECK2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAETSKLINIKUM JENA2
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITEIT TWENTE2
UNIVERSITEIT UTRECHT2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF LEEDS2
UNIVERSITY OF OSLO2
UPPSALA UNIVERSITET2
WEIZMANN INSTITUTE OF SCIENCE2
ABBVIE DEUTSCHLAND GMBH & CO KG1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ADELPHI VALUES1
AIBIOPHARMA1
AICURIS ANTIINFECTIVE CURES1
AMC MEDICAL RESEARCH BV1
AMGEN1
AMGEN RESEARCH1
ANTAROS MEDICAL AB1
APPLIED RESEARCH USING OMIC SCIENCES SL1
ARLENDA1
ARTEEVO TECHNOLOGIES1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
Constancy:

Total number of partners:579

Partner loyalty:
Frequent Partner: (> 2 projects): 201
Rare Partner: 378

Frequent / Rare Partner Ratio: 0.53

Diversity:

Subjects: Diversity index:0.43
Categories:
Category:No:
INDUSTRY AND TECHNOLOGY1
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82545
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-06-01Stratification of Obese Phenotypes to Optimize Future Obesity Therapy SOPHIAparticipant8.301.00029
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18637
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2020-01-01INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition. INSPIREparticipant4.021.96911
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-09-01Proton transport and proton-coupled transport PROTONparticipant3.976.97612
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-05-01ENdoThelial macRophage Alliance In Neuroinflammation ENTRAINparticipant3.664.17420
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-09-01Targeting the metabolism-immune system connections in Cancer META-CANparticipant3.831.95820
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023
2016-03-01Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 VAC2VACparticipant7.850.00023
2016-01-01Big Data in Chemistry BIGCHEMparticipant2.540.14617
2013-11-01From DISCOvery to products: A next generation pipeline for the sustainable generation of high-value plant products DISCOparticipant6.485.84715
2012-10-01Interdisciplinary training network for Tourette Syndrome; structuring European Training capacities for neurodevelopmental disorders TS-EUROTRAINparticipant3.076.39810
2012-04-01Mucus Permeating Nanoparticulate Drug Delivery Systems ALEXANDERparticipant8.098.20218
2010-12-01Transport and signalling in Polarized Cells TRANSPOLparticipant3.835.98011
2010-02-01"Development of Vaccines for bTV, EHDV and AHSV" ORBIVACparticipant2.999.72918
2010-01-01New tools and approaches to control Porcine Reproductive and Respiratory Syndrome (PRRS) in the EU and Asia PoRRSConparticipant2.999.07016

Alias institution names:
  • BOEHRIGER INGELHEIM INTERNATIONAL
  • BOEHRINGER INGELHEIM INTERNATIONALGMBH
  • BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
  • BOEHRINGER INGELHEIM PHARMA GMBH &CO KG
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG
  • BOEHRINGER INGELHEIM VETMEDICA

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum